Logo

GATC Signs $3.2M DNA-Sequencing Contract with Medical Research Council

May 26, 2006

NEW YORK, May 26 (GenomeWeb News) - GATC Biotech today said it has signed a €2.5-million ($3.2 million) DNA-sequencing contract with the Medical Research Council.

According to the contract, GATC will provide the MRC's 35 sites in the United Kingdom with DNA sequencing services over a period of at least three years in return for about €2.5 million.

The MRC said it selected GATC over 10 other potential DNA sequencing service providers. A key selling point for GATC was its "fully automated sequencing process that reduces the level of human intervention and error," GATC said.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.